Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy

INTRODUCTION: The optimal duration of dual anti-platelet therapy (DAPT) following percutaneous coronary intervention (PCI) is still a matter of debate. Biomarkers may help to identify patients who will benefit from extended DAPT. The aim of the study was to test the interaction between lipid paramet...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Arch Med Sci
Hoofdauteurs: Jäger, Bernhard, Piackova, Editha, Haller, Paul Michael, Andric, Tijana, Kahl, Beatrice, Christ, Günther, Geppert, Alexander, Wojta, Johann, Huber, Kurt
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Termedia Publishing House 2018
Onderwerpen:
Clinical Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6348363/
https://ncbi.nlm.nih.gov/pubmed/30697254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2018.81035
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items